Omnipod 5 DEXG7G6 pods (GEN 5) 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FV906
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,056
Award facts
- Contract value 100% obligated
- $51,055.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $51,055.60 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods, with performance in Conshohocken, Pennsylvania and completion scheduled for January 30, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a routine pharmaceutical supply transaction under the DLA's medical procurement operations. AmerisourceBergen, a major pharmaceutical distributor and subsidiary of Cencora, Inc., serves as the prime contractor and leverages its extensive federal contracting experience to fulfill critical medical supply needs for military and veteran healthcare systems.
This delivery order is executed under Cencora's comprehensive Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 through December 31, 2031. The parent IDC functions as a global pharmaceutical support vehicle enabling the delivery of brand-name and generic medications, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The DLA Medical Supply Chain relies on such prime vendor arrangements to efficiently distribute essential pharmaceutical products, including specialized diabetes management devices like the OmniPod 5 system paired with continuous glucose monitoring technology, to support the healthcare requirements of active-duty personnel, military treatment facilities, and veteran populations.
Quick answers
Who was awarded contract SPE2DR26FV906?
SPE2DR26FV906 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FV906 worth?
The government has obligated $51,056 on SPE2DR26FV906.
Is contract SPE2DR26FV906 an order under another contract?
Yes. SPE2DR26FV906 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV906 competed?
The extent of competition for SPE2DR26FV906 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award